Glycoprotein IIb/IIIa antagonism and fibrinolytic therapy for acute myocardial infarction (Q28193195)

acute myocardial infarction

Europe PubMed Central

title

Glycoprotein IIb/IIIa antagonism and fibrinolytic therapy for acute myocardial infarction (English)

0 references

main subject

myocardial infarction

1 reference

based on heuristic

inferred from title

1 reference

3

David J Moliterno

0 references

author name string

Deepak P Vivekananthan

series ordinal

1

0 references

Vasant B Patel

series ordinal

2

0 references

language of work or name

English

0 references

publication date

April 2002

0 references

published in

Journal of Interventional Cardiology

0 references

volume

15

0 references

issue

2

0 references

page(s)

131-9

0 references

cites work

An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators

1 reference

https://api.crossref.org/works/10.1111/J.1540-8183.2002.TB01045.X

Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1540-8183.2002.TB01045.X

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1540-8183.2002.TB01045.X

Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1540-8183.2002.TB01045.X

Extent of early ST segment elevation resolution: a strong predictor of outcome in patients with acute myocardial infarction and a sensitive measure to compare thrombolytic regimens. A substudy of the International Joint Efficacy Comparison of Thromb

21 April 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2002.TB01045.X

Illusion of reperfusion. Does anyone achieve optimal reperfusion during acute myocardial infarction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2002.TB01045.X

Effect of heparin on coronary arterial patency after thrombolysis with tissue plasminogen activator in acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2002.TB01045.X

Toward a new frontier in myocardial reperfusion therapy: emerging platelet preeminence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2002.TB01045.X

Mediation of reocclusion by thromboxane A2 and serotonin after thrombolysis with tissue-type plasminogen activator in a canine preparation of coronary thrombosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2002.TB01045.X

Kistrin, a polypeptide platelet GPIIb/IIIa receptor antagonist, enhances and sustains coronary arterial thrombolysis with recombinant tissue-type plasminogen activator in a canine preparation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2002.TB01045.X

Acceleration of recombinant tissue-type plasminogen activator-induced thrombolysis and prevention of reocclusion by the combination of heparin and the Arg-Gly-Asp-containing peptide bitistatin in a canine model of coronary thrombosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2002.TB01045.X

Pharmacokinetics and pharmacodynamics of TP-9201, a gpIIbIIIa antagonist, administered in combination with recombinant tissue-type plasminogen activator, heparin, and aspirin in beagles

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2002.TB01045.X

Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2002.TB01045.X

Current role of platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2002.TB01045.X

Abciximab and early adjunctive percutaneous coronary intervention are associated with improved ST-segment resolution after thrombolysis: Observations from the TIMI 14 Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2002.TB01045.X

Low-molecular-weight heparin in the treatment of patients with venous thromboembolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2002.TB01045.X

Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2002.TB01045.X

Combining thrombolysis with the platelet glycoprotein IIb/IIIa inhibitor lamifiban: results of the Platelet Aggregation Receptor Antagonist Dose Investigation and Reperfusion Gain in Myocardial Infarction (PARADIGM) Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2002.TB01045.X

Eptifibatide and low-dose tissue plasminogen activator in acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2002.TB01045.X

Effect of age on outcome with primary angioplasty versus thrombolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2002.TB01045.X

Facilitation of early percutaneous coronary intervention after reteplase with or without abciximab in acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2002.TB01045.X